UnitedHealth Group (UNH) EVP McSweeney discloses 38.566-share Form 4 update
Rhea-AI Filing Summary
UnitedHealth Group executive reports routine share accrual tied to awards
UnitedHealth Group executive Erin L. McSweeney, EVP & Chief People Officer, reported an acquisition of 38.566 shares of UnitedHealth Group common stock on 12/16/2025. The filing explains that this amount represents dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying awards and are forfeited if those units do not vest. After this transaction, McSweeney beneficially owned a total of 11,192.638 shares of common stock in direct form.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 38.566 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did UNH executive Erin L. McSweeney report?
Erin L. McSweeney reported acquiring 38.566 shares of UnitedHealth Group common stock on 12/16/2025, as shown in the Form 4.
What is Erin L. McSweeney’s role at UnitedHealth Group (UNH)?
Erin L. McSweeney is listed as an officer of UnitedHealth Group, holding the title EVP & Chief People Officer.
Were any UNH derivative securities reported in this Form 4?
The table for derivative securities is included but shows no derivative transactions reported in the provided excerpt.
Who signed the Form 4 for UnitedHealth Group executive Erin L. McSweeney?
The Form 4 was signed by Faraz A. Choudhry as Attorney-in-Fact for Erin L. McSweeney on 12/18/2025.